Energy and Nutrients consumption in patients with Alzheimer’s disease (AD)
DOI:
https://doi.org/10.17533/udea.penh.18064Keywords:
Alzheimer’s disease, stage of the disease, energy intake, micronutrients, agedAbstract
The energy and nutrients consumption in patients with Alzheimer's disease (AD) are compromised by physiological, socioeconomic and psychological changes related to the disease, in addition to aging process.Objective: To evaluate energy and nutrients consumption in a group of patients with AD, that were recruited from the Neuroscience Group of the University of Antioquia - Medellin. It was done according to disease stage. Methods: It is a cross-sectional descriptive study. To obtain the data of food consumption, a 24 hours recall questionnaire was applied in three different days, in addition one day during weekend. Results: 68 patients were evaluated, with average age of 65.5 ± 12.8 years; the most frequent disease stage found was moderate. There were no significant differences in the consumption of the nutrients and energy according to disease stage; energy consumption was more altered in moderate stage; the protein consumption was adequate in severe, and excessive in mild and moderate stages. For micronutrients such as calcium, magnesium, B6 vitamin and folic acid, intake were assumed to be insufficient. Conclusion: it is indispensable to implement an opportune and continuous nutritional care for patients suffering AD, moreover nutritional education for their families in issuesrelated to nutritional attention is necessary.
Downloads
References
Kivipelto M, Hellkala EL, Laakso MP, Aniñen T, Hallikainen M, Alhainen K et al. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ 2001; 322(7300):1447-51.
Arango V E, Jaquier M, Cano C. Escalas funcionales de la vida diaria versus MMSE (Minimentasl) en la detección temprana de la demencia tipo Alzheimer. Influencia del Genotipo APOE. Vniversitas Medicas (revista en linea) 2001;42(3) URL: http://med.javeriana.edu.co/publi/vniversitas.
White H, Pieper C, Schmader K, Fillenbaum G. A Longitudinal analysis of weight change in Alzheimer’s disease. J Am Geriatr Soc 1997 45:531-2.
Guyonnet S, Nourhashemi F, Andrieu S, Ousset PJ, Gray LK, Fitten LJ et al. A prospective study of changes in nutritional status in Alzheimer’s patients. Arch Gerontol Geriatr 1998;26: 255-62.
Berlinger WG, Potter JF. Low body mass index in demented outpatients. J Am Geriatr Soc 1991;39:973-8.
Shiveley LR, Connolly PJ. Nutrioterapia médica en trastornos neurológicos. En: Nutrición y dietoterápia de Krause. 10 ed. México: Mc Graw-Hill Interamericana; 2001. P. 1023-27.
Alberca, R. Tratamiento de las alteraciones conductuales en la enfermedad de Alzheimer y en otros procesos neurológicos. México: Editorial Médica Panamericana; 2002.
Riviere S, Guyonnet SG, Nourhashemi F,Vellas B. Nutrition and Alzheimer’s disease. Nutr Rev 1999;57:363-7.
Falque L. Enfermedad de Alzheimer y nutrición. Ann Ven Nutr 1999;12:28-32.
Ibarzo M A. Alzheimer. Consejos para una buena alimentación. Sociedad Española de Enfermería Neurológica. Novartis Consumer Health.A. [Sitio en Internet] URL: http://www.novartisconsumerhealth.es/mantenimiento/estudio [Fecha de acceso julio de 2004]
Lopera F. Alzheimer y otros trastornos neurodegenerativos en Antioquia. Innov Cien 1999;8:80.
Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988;24:653-9.
Reisberg B, Ferris SH, Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psy 1982;139:1136-9.
Manjarres LM, Correa JM. Software de análisis de consumo de alimentos ECA1. Medellín; 2004.
Instituto Colombiano de Bienestar Familiar. Tabla de composición de alimentos colombianos.4 ed. Bogota; 1978.
FAO. Tabla de composición de alimentos de América Latina. 2002 [Sitio en Internet] URL http://www.rlc.fao.org/bases/alimento.
Institute of Medicine of the National Academies. Energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington: National Academies Press; 2002.
Murphy S, Barr S, Poos M. Using the new dietary reference intakes to assess diets: a map to the maze. Nutr Rev 2002;60:267-75.
Guérin O, Andrieu S, Schneider SM, Milano M, Boulahssass R, Brocker P. Different modes of weight loss in Alzheimer disease: a prospective study of 395. Am J Clin Nutr 2005;82:435-41.
Cronin-Stubbs D, Beckett LA, Scherr PA. Weight loss in people with Alzheimer’s disease: a prospective population based analysis, BMJ 1997;314:178-9.
Wang PN, Yang CL, Lin KN, Chen WT, Chwang LC, Liu HC. Weight loss, nutritional status and physical activity in patients with Alzheimer’s disease. A controlled study. J Neurol 2004;251:314-20.
Greenwood CE, Tam C, Chan M, Young KWH, Binns MA, Van Reekum R. Behavioral disturbances, not cognitive deterioration, associates with altered food selection in seniors with Alzheimer’s disease. J Gerontol A Biol Sci Med Sci 2005;60:499-505.
Young KWH, Binns MA, Greenwood CE. Meal delivery practices do not meet needs of Alzheimer patients with increased cognitive and behanvioral difficulties in a long-term care facility. J Gerontol Series A Biol Sci Med Sci 2001;56:M656-61.
Botella JJ, Ferrero M. La alimentación del enfermo de Alzheimer en el ámbito familiar. Nutr Hosp 2004;29:154-9.
Gil GP, Ramirez SP, Ribera JM; DEMENU group. Dementia and nutrition. Intervention study in institutionalized patients with Alzheimer disease. J Nutr Health Aging 2003;7:304-8.
White H, McConnell E, Bales C, Kuchibhatla M. A 6-Month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer’s disease subjects. J Am Med Dir Assoc 2004;5:89-97.
Poehlman ET, Dvorak RV. Energy expenditure, energy intake, and weight loss in Alzheimer
Donaldson KE, Carpenter WH, Toth MJ, Goran MI, Newhouse P, Poehlman ET. No evidence for a higher resting metabolic rate in noninstitutionalized Alzheimer’s disease patients. J Am Geriatr Soc 1996;44:1232-4.
Walrand S, Boirie Y. Optimizing protein intake in aging. Curr Opin Clin Nutr Metab Care 2005;8:89-94.
Kimura M. Magnesium for nutrition. Clin Calcium 2005;15:1778-84.
Seshadri S, Wolf PA. Homocysteine and the brain: vascular risk factor or neurotoxin? Lancet Neurol 2003;2:11.
Selhub J, Bagley LC, Miller J, Rosenberg IH: B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000;71;614S-20S.
Bots ML, Launer L, Lindemans J, Hofman A, Grobbee D. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: the Rotterdam study. J Intern Med 1997;242:339-47.
Sato S, Kanoko T, Satoh K, Iwamoto J. Risk factors for hip fracture among elderly patients
with Alzheimer's Disease. J Neurol Sci 2004;223:107-12.
Garruto RM, Yase Y. Neurodegenerative disorders of the western Pacific: the search for mechanisms of patogénesis. Trends Neurosci 1986; :368-74.
Arai K, Sumi Y, Uematsu H, Miura H. Association between dental health behaviours, mental/ physical function and self-feeding ability among the elderly: a cross-sectional survey. Gerodontology 2003;20:78-83.
Chew BP, Park JS. Carotenoid action on the immune response. J Nutr 2004;134:257S-61S.
Kawaura A, Nishida Y, Takeda E. Phosphorus intake and bone mineral density (BMD). Clin
Calcium 2005;15:1501-1506.
Ibarzo M A. Manual de alimentación del paciente neurológico. Sociedad Española de
Enfermería Neurológica; Novartis Consumer Health [Sitio en Internet] URL http://www.novartisconsumerhealth.es/mantenimiento/estudio. (Fecha de acceso 2 de octubre 2002)
Planas M, Conde M, Audivert S, Perez-PortabellaC, Burgos R, Chacon P et al. Micronutrient supplementation in mild Alzheimer disease patients. Clin Nutr 2004;23:265-72.
Downloads
Published
How to Cite
Issue
Section
License
Derechos de autor 2024 Universidad de Antioquia
